News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
13,211 Results
Type
Article (529)
Company Profile (2)
Press Release (12680)
Section
Business (3144)
Career Advice (4)
Deals (617)
Drug Development (2141)
FDA (782)
Job Trends (231)
News (7191)
Policy (1070)
Tag
Academia (26)
Allergies (4)
Alliances (842)
ALS (2)
Alzheimer's disease (30)
Approvals (783)
Bankruptcy (8)
Best Places to Work (198)
Biotechnology (2)
Breast cancer (3)
Cancer (13)
Career advice (4)
Cell therapy (2)
Clinical research (1910)
Collaboration (7)
Compensation (9)
COVID-19 (31)
Cystic fibrosis (7)
Data (42)
Diabetes (3)
Diagnostics (60)
Drug discovery (5)
Earnings (1582)
Events (1477)
FDA (804)
Funding (7)
GLP-1 (23)
Government (80)
Healthcare (174)
Huntington's disease (3)
Infectious disease (35)
Inflammatory bowel disease (4)
Interviews (2)
IPO (246)
Job creations (38)
Job search strategy (2)
Layoffs (7)
Legal (200)
Lung cancer (2)
Manufacturing (5)
Medical device (67)
Medtech (67)
Mergers & acquisitions (375)
Metabolic disorders (10)
Neuropsychiatric disorders (2)
Neuroscience (45)
NextGen Class of 2024 (118)
Non-profit (6)
Northern California (53)
Obesity (5)
Opinion (4)
Pain (2)
Parkinson's disease (3)
Patents (2)
Peanut (2)
People (521)
Phase I (370)
Phase II (731)
Phase III (842)
Pipeline (11)
Postmarket research (121)
Preclinical (108)
Psychedelics (6)
Radiopharmaceuticals (2)
Rare diseases (13)
Real estate (92)
Regulatory (821)
Research institute (22)
RSV (2)
Schizophrenia (4)
Series B (1)
Southern California (39)
Startups (40)
United States (305)
Weight loss (4)
Date
Last 7 days (10)
Last 30 days (39)
Last 365 days (676)
2024 (672)
2023 (748)
2022 (1337)
2021 (1026)
2020 (891)
2019 (921)
2018 (712)
2017 (664)
2016 (674)
2015 (918)
2014 (620)
2013 (533)
2012 (560)
2011 (540)
2010 (419)
Location
Africa (7)
Arizona (4)
Asia (1621)
Australia (142)
California (109)
Canada (33)
China (5)
Colorado (2)
Connecticut (4)
Europe (1489)
Florida (13)
Indiana (3)
Japan (2)
Maryland (7)
Massachusetts (54)
Michigan (2)
Nebraska (2)
New Jersey (35)
New York (37)
North Carolina (24)
Northern California (53)
Pennsylvania (5)
South America (20)
Southern California (39)
Texas (2)
13,211 Results for "capsule technologie".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Dr. Reddy’s Laboratories Announces the Launch of Doxycycline Capsules, 40 mg* in the U.S.
Dr. Reddy’s Laboratories Ltd. today announced its launch of Doxycycline Capsules, 40 mg* in the U.S. market, a therapeutic generic equivalent of ORACEA® (doxycycline, USP) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA).
May 3, 2024
·
3 min read
Press Releases
Vantage Nutrition to launch groundbreaking higher concentration VitaCholine® into liquid capsules
October 30, 2024
·
1 min read
FDA
Neurocrine Biosciences Announces U.S. FDA Approval of INGREZZA® SPRINKLE (valbenazine) Capsules
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration has approved INGREZZA® SPRINKLE (valbenazine) capsules, a new oral granules formulation of INGREZZA® (valbenazine) capsules prescribed for the treatment of adults with tardive dyskinesia and chorea associated with Huntington’s disease.
April 30, 2024
·
12 min read
Press Releases
Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China’s National Medical Products Administration
December 20, 2024
·
7 min read
Essential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules
Essential Pharma announces that it has completed the acquisition of Reminyl® oral capsules from Janssen Pharmaceutica NV, a Johnson & Johnson company.
April 17, 2024
·
3 min read
Press Releases
Optimi Health Announces First PTSD Patients Treated with MDMA Capsules in Australia
October 23, 2024
·
5 min read
Pharm Country
Glenmark Pharmaceuticals Inc., USA Issues Voluntary Nationwide Recall for Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K Due To Failed Dissolution
Glenmark Pharmaceuticals Inc. is voluntarily recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP 10 mEq K, to the consumer level.
June 25, 2024
·
13 min read
Press Releases
FDA Clears Abionic’s IVD CAPSULE PSP for the Early Detection of Sepsis
October 2, 2024
·
3 min read
Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations
Ovid Therapeutics Inc. and Graviton Bioscience Corporation today announced the results from their Phase 1 healthy volunteer study evaluating the safety, tolerability, and pharmacokinetic (PK) profile of multiple ascending doses of OV888/GV101 capsule.
July 1, 2024
·
9 min read
FDA
Epitomee Medical Announces FDA Clearance of its Capsule, Weight Management Device
September 16, 2024
·
5 min read
1 of 1,322
Next
